comparemela.com

Latest Breaking News On - Carll gordon - Page 3 : comparemela.com

BTIG Research Trims Adicet Bio (NASDAQ:ACET) Target Price to $10.00

BTIG Research Trims Adicet Bio (NASDAQ:ACET) Target Price to $10.00
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Adicet-bio
Carll-gordon
Jpmorgan-chase-co
Alpine-global-management
Carlyle-group-inc
Nasdaq
Jump-financial
Adicet-bio-inc
Free-report
Director-carl
Global-management
Carlyle-group

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Carll-gordon
Stifel-nicolaus
Barclays-plc
Theseus-pharmaceuticals
Securities-exchange-commission
Theseus-pharmaceuticals-company-profile
Theseus-pharmaceuticals-price-performance
Nasdaq
American-international-group-inc
News-ratings-for-theseus-pharmaceuticals-daily

Wedbush Reiterates "Outperform" Rating for Theseus Pharmaceuticals (NASDAQ:THRX)

Wedbush Reiterates "Outperform" Rating for Theseus Pharmaceuticals (NASDAQ:THRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Carll-gordon
Stifel-nicolaus
Needham-company
Institutional-investors-weigh-in-on-theseus-pharmaceuticals
Citigroup-inc
York-mellon-corp
Analyst-recommendations-for-theseus-pharmaceuticals
Charles-schwab-investment-management-inc
Theseus-pharmaceuticals
Cantor-fitzgerald
Dimensional-fund-advisors
Principal-financial-group-inc

Adicet Bio (ACET) Scheduled to Post Quarterly Earnings on Tuesday

Adicet Bio (NASDAQ:ACET – Get Free Report) is scheduled to announce its earnings results on Tuesday, August 8th. Adicet Bio (NASDAQ:ACET – Get Free Report) last announced its quarterly earnings data on Tuesday, May 9th. The company reported ($0.72) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.02. On […]

Carll-gordon
Adicet-bio
Adicet-bio-inc
Geode-capital-management
Cubist-systematic-strategies
Jpmorgan-chase-co
Get-free-report
Director-carl
Street-group
Capital-management
Adicet-bio-daily
Nasdaq-acet

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update

Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 2,960,000 shares, a decrease of 5.7% from the June 30th total of 3,140,000 shares. Based on an average trading volume of 835,400 shares, […]

Switzerland
United-states
American
Swiss
Carll-gordon
Adicet-bio
Swiss-national-bank
Jpmorgan-chase-co
Adicet-bio-company-profile
Sg-americas-securities
Nasdaq
Adicet-bio-inc

vimarsana © 2020. All Rights Reserved.